Van Gaal LF - Search Results

1

PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.

Mertens I, Lemieux I, Verrijken A, Després JP, Van Gaal LF. Mertens I, et al. Among authors: van gaal lf. Diabetes Metab Res Rev. 2008 Feb;24(2):141-7. doi: 10.1002/dmrr.779. Diabetes Metab Res Rev. 2008. PMID: 17922472

2

Carbohydrate-induced thermogenesis in obese women. Effect of insulin and catecholamines.

Van Gaal L, Mertens I, Vansant G, De Leeuw I. Van Gaal L, et al. J Endocrinol Invest. 1999 Feb;22(2):109-14. doi: 10.1007/BF03350889. J Endocrinol Invest. 1999. PMID: 10195377 Clinical Trial.

3

Are leptin levels dependent on body fat distribution in obese men and women?

Wauters M, Mertens I, Considine R, De Leeuw I, Van Gaal L. Wauters M, et al. Eat Weight Disord. 1998 Sep;3(3):124-30. doi: 10.1007/BF03339999. Eat Weight Disord. 1998. PMID: 10728161

4

Associations of leptin with body fat distribution and metabolic parameters in non-insulin-dependent diabetic patients: no effect of apolipoprotein E polymorphism.

Wauters M, Considine R, Löfgren A, Van Broeckhoven C, Van der Auwera JC, De Leeuw I, Van Gaal L. Wauters M, et al. Metabolism. 2000 Jun;49(6):724-30. doi: 10.1053/meta.2000.6255. Metabolism. 2000. PMID: 10877196 Clinical Trial.

5

Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance.

Wauters M, Mertens I, Rankinen T, Chagnon M, Bouchard C, Van Gaal L. Wauters M, et al. J Clin Endocrinol Metab. 2001 Jul;86(7):3227-32. doi: 10.1210/jcem.86.7.7682. J Clin Endocrinol Metab. 2001. PMID: 11443193

6

Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women.

Mertens I, Van der Planken M, Corthouts B, Wauters M, Peiffer F, De Leeuw I, Van Gaal L. Mertens I, et al. Horm Metab Res. 2001 Oct;33(10):602-7. doi: 10.1055/s-2001-17907. Horm Metab Res. 2001. PMID: 11607880

7

Leptin levels, leptin receptor gene polymorphisms, and energy metabolism in women.

Wauters M, Considine RV, Chagnon M, Mertens I, Rankinen T, Bouchard C, Van Gaal LF. Wauters M, et al. Among authors: van gaal lf. Obes Res. 2002 May;10(5):394-400. doi: 10.1038/oby.2002.54. Obes Res. 2002. PMID: 12006639 Free article.

8

Health risks of lipodystrophy and abdominal fat accumulation: therapeutic possibilities with leptin and human growth hormone.

Van Gaal LF, Mertens IL, Abrams PJ. Van Gaal LF, et al. Growth Horm IGF Res. 2003 Aug;13 Suppl A:S4-9. doi: 10.1016/s1096-6374(03)00046-7. Growth Horm IGF Res. 2003. PMID: 12914718 Review.

9

Modern, new pharmacotherapy for obesity. A gastrointestinal approach.

Van Gaal L, Mertens I, Ballaux D, Verkade HJ. Van Gaal L, et al. Best Pract Res Clin Gastroenterol. 2004 Dec;18(6):1049-72. doi: 10.1016/j.bpg.2004.09.001. Best Pract Res Clin Gastroenterol. 2004. PMID: 15561638 Review. No abstract available.

10

Effects of micronized fenofibrate and vitamin E on in vitro oxidation of lipoproteins in patients with type 1 diabetes mellitus.

Engelen W, Manuel-y-Keenoy B, Vertommen J, De Leeuw I, Van Gaal L. Engelen W, et al. Diabetes Metab. 2005 Apr;31(2):197-204. doi: 10.1016/s1262-3636(07)70186-6. Diabetes Metab. 2005. PMID: 15959426 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

286 results

Search Page

Filters